Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepi… homo-4-mer 519-794
100.0 8×MG; 4×92M; HUMAN MPS1 IN COMPLEX WITH NMS-P715 homo-2-mer 515-795
100.0 2×SVE; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … homo-2-mer 516-794
98.84 2×5NW; 2×DMS; Crystal structure of TTK kinase domain monomer 515-796
100.0 Crystal structure of TTK kinase domain in complex with compound 7 monomer 515-795
100.0 1×FZR; Crystal structure of TTK kinase domain in complex with compound 9 monomer 515-795
100.0 1×FZL; Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine monomer 514-794
100.0 1×7PE; 1×STU; 3×IPA; 4×GOL; Human Mps1 kinase domain with ordered activation loop monomer 515-795
100.0 6×GOL; 2×CL; Crystal structure of TTK kinase domain in complex with compound 28 monomer 515-795
100.0 1×G0U; Human TTK in complex with a Dyrk1B inhibitor monomer 513-793
99.6 1×DYK; Crystal Structure of TTK kinase domain with an inhibitor: 400740 monomer 515-794
100.0 4×PO4; 1×1PH; 10×EDO; Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor monomer 516-795
100.0 1×GOL; 1×PEG; 6×EDO; 1×052; Crystal structure of TTK kinase domain in complex with compound 30 monomer 515-794
100.0 1×FZO; 2×MG; CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridi… monomer 516-795
100.0 8×IOD; 1×O22; Crystal structure of the human TTK in complex with an inhibitor monomer 515-794
100.0 1×KE7; 1×1PE; 1×EDO; X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16 monomer 515-794
100.0 1×NN5; Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol… monomer 516-795
100.0 1×1O5; Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor monomer 516-795
99.61 1×537; 1×7PE; Crystal structure of TTK kinase domain in complex with compound 19 monomer 516-795
100.0 1×G5C; CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1… monomer 516-795
100.0 1×IOD; 1×O38; CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)-3-(4-((6-(((3s,5s,7s)-adamanta… monomer 516-795
100.0 1×O17; Crystal structure of TTK kinase domain with an inhibitor: 401348 monomer 515-793
100.0 1×1PF; 2×SO4; 2×PEG; 2×GOL; CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-yl… monomer 516-794
100.0 1×CL; 1×O23; Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4 monomer 516-794
100.0 1×CX4; 1×7PE; 1×PEG; 3×GOL; 3×IPA; X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46 monomer 516-794
100.0 1×O23; 1×CL; Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]… monomer 515-793
100.0 1×2QK; 1×GOL; Crystal structure of TTK kinase domain in complex with compound 8 monomer 516-794
100.0 1×FZF; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 516-794
98.83 1×5O7; Crystal structure of human Mps1 catalytic domain in complex with ATP monomer 516-794
100.0 1×ATP; 1×7PE; CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrah… monomer 516-794
100.0 1×O43; Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715 monomer 519-797
99.63 1×SVE; 2×EDO; TTK in Complex with Inhibitor monomer 515-793
100.0 1×CQ7; 1×CAC; Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form monomer 516-794
100.0 1×7PE; X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79 monomer 516-793
100.0 1×8RH; X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41 monomer 517-794
100.0 1×8QW; 1×CL; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 519-796
100.0 1×0SQ; Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5 monomer 519-796
99.62 1×C5N; 1×EDO; Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor monomer 519-795
100.0 1×YB4; 5×GOL; 1×TOE; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-795
100.0 1×O38; 4×GOL; 3×MG; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-795
100.0 1×AU5; 2×P4C; 3×DMS; 13×EDO; Crystal structure of human Mps1 (TTK) in complex with Cpd-5 monomer 519-795
99.61 1×C5N; 12×EDO; 1×CL; Crystal structure of human Mps1 (TTK) in complex with Reversine monomer 519-795
99.61 1×AD5; 1×EDO; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 519-794
100.0 1×5OQ; 2×DMS; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
99.61 1×PWU; 10×EDO; 1×DMS; TTK kinase domain in complex with TC-Mps1-12 monomer 519-794
100.0 1×8QE; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 519-794
100.0 1×5O1; 1×DMS; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 519-794
100.0 7×7PE; 1×5O4; 5×EDO; 1×DMS; TTK kinase domain in complex with NTRC 0066-0 monomer 519-794
100.0 1×N66; 1×PGF; 1×NA; Crystal structure of human dual specificity protein kinase (TTK) monomer 519-794
100.0 2×7PE; TTK kinase domain in complex with BAY 1161909 monomer 519-794
100.0 1×8QW; TTK kinase domain in complex with Mps-BAY2b monomer 519-794
100.0 1×8Q5; 5×NA; 1×PG0; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 3×7PE; 1×7CE; 3×EDO; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
99.61 1×SVE; 5×EDO; 1×DMS; Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enab… monomer 519-794
100.0 1×FMW; 1×7PE; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 1×X21; MPS1 kinase with 3-aminopyridin-2-one inhibitors monomer 519-794
100.0 1×W2K; 5×EDO; 1×DMS; MPS1 kinase with 3-aminopyridin-2-one inhibitors monomer 519-794
100.0 1×WBI; 2×DMS; 2×EDO; TTK kinase domain in complex with MPI-0479605 monomer 519-794
100.0 1×8PT; 2×7PE; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 1×4T9; 1×1PE; 4×7PE; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 1×7RO; 2×7PE; 2×EDO; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 1×X20; 1×7PE; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
99.6 4×7PE; 1×AU5; 1×DMS; 3×EDO; Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor monomer 519-794
100.0 4×7PE; 1×ZO6; 4×EDO; Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin l… monomer 519-794
100.0 1×S22; 2×7PE; TTK kinase domain in complex with BAY 1217389 monomer 519-794
100.0 1×8RH; Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 monomer 519-794
100.0 1×7RO; 1×7PE; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
99.6 1×7RO; 1×1KA; 1×PGE; 2×EDO; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
100.0 1×PWU; Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor monomer 519-794
100.0 2×7PE; 1×Z0W; 1×EDO; Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor monomer 519-794
100.0 2×7PE; 1×Z0B; 1×EDO; Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. monomer 519-794
99.61 1×O38; 2×7PE; 2×EDO; TTK kinase domain in complex with a PEG-linked pyrimido-indolizine monomer 519-794
100.0 1×8QZ; MPS1 kinase with 3-aminopyridin-2-one inhibitors monomer 519-794
100.0 1×3D7; 4×EDO; Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor monomer 519-794
100.0 2×EDO; 1×7PE; 1×ZO8; Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a … monomer 519-753
100.0 1×5OE; 3×DMS; Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin… monomer 59-199
100 Crystal structure of human Mps1 TPR domain monomer 62-199
100 1×PG4; 2×GOL; Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin… monomer 59-196
100 1×PB;